Antimicrobial Stewardship

Antimicrobial Stewardship (AMS) is the means to fight against antimicrobial resistance (AMR). To help ensure antibiotics remain effective, hospital-based stewardship programs promote and monitor their appropriate use. AMS therefore helps fight the rise of Multidrug Resistant Organisms (MDRO) and prevents outbreaks of healthcare-acquired infections (HAI). Diagnostics are a key part of AMS programs. They provide information, data and results throughout the patient pathway.

Add to your selection

Do you need more information?

What is Antimicrobial Resistance (AMR) ?

AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.

How does Antibiotic resistance occur ?

Enlarge

Source: CDC

 

The development of resistant bacteria is a natural phenomenon that is exacerbated and accelerated by the inappropriate use of antibiotics in the fields of human and animal health and the inadequate infection control.

The cost is high, If we do not address AMR now

Every 45 seconds someone dies from an infection caused by a resistant bacteria

Source: WHO (October 27th)

 

Act now: It’s the only way we will reduce the threat of resistance

Antimicrobial Stewardship (AMS) is critical to fight the AMR crisis. AMS programs help fight antimicrobial resistance by providing a framework for responsible antibiotics prescribing and use, optimizing individual therapy, helping reduce the spread of resistance and raising awareness & education.

bioMérieux: your partner of choice on AMS

Put diagnostics at the heart of Antimicrobial Stewardship to drive informed therapy decisions.

bioMérieux has the most comprehensive solutions on the market all along the patient pathway:

Enlarge

 

Product availability varies by country. Consult your bioMérieux sales representative.

 

Our complete AMS solution encompasses more than just traditional state-of-the-art lab technology. Because at bioMérieux we fully understand your antimicrobial stewardship (AMS) needs our offer translates into 4 key areas where we help hospitals and labs worldwide evolve to suit today’s needs and tomorrow’s concerns:



Diagnostic solutions

Provide fast and actionable infectious disease diagnostic tools to support responsible use of antimicrobials from antibiotics initiation, to optimization, to discontinuation



Advanced analytics

Gain a holistic view and start connecting diagnostics to therapeutic decisions and connect the decisions to outcomes



Consultancy services

Improve lab efficiency and accelerate the medical and economic value of stewardship



Educational modules

Educate hospital stakeholders to ensure Antimicrobial Stewardship programs success

 

How can we help the lab?

We accompany you with a tailored offer to leverage your diagnostic expertise and ensure clinicians optimize therapy sooner. bioMérieux can support you to provide relevant laboratory data to optimize antibiotic therapy

MYLA

Provide up-to-date Antibiogram Reports to help empiric therapy decisions
BIOMERIEUX LAB CONSULTANCY

Reduce time-to-results by streaming processes and optimizing resource use
VIDAS BRAHMS PCT

Evaluate whether to start antibiotic therapy and establish a baseline for monitoring patient response to antibiotic therapy
PREVI COLOR GRAM

Guide treatment options through rapid standardized Gram stain results
BIOFIRE FILMARRAY SYSTEMS

Reduce time to optimal therapy, shorten patient stay and avoid unnecessary testing

BACT/ALERT VIRTUO

Earlier optimization of antibiotic therapy and improved blood culture monitoring practices from an even faster and integrated time to result
BIOFIRE BCID2 PANEL

Detect 43 targets including 10 AMR genes in about 1 hour to help optimize patient treatment decision & improve outcomes
WASP & WASPLab

Flexible automated specimen processing and reading solution for a faster time to result with a focus only on specimens with clinical interest
VITEK MS PRIME

Maximize daily routine workflow with enhanced productivity for faster time to reported results to positively impact patient care
VITEK 2

Optimize therapy decisions with same-day expertized AST results
CHROMID range

One-step isolation and direct identification of major pathogens responsible for infection
ETEST

Extensive MIC information of new and existing antibiotics to further optimize patient therapy
RAPIDEC CARBA NP

Detection and confirmation of carbapenemase-producing Gram-negative bacilli
VIDAS BRAHMS PCT

Monitor patient response to antibiotic therapy
MYLA

Optimize therapy with value-added comprehensive results and streamlined workflow
BIOMERIEUX EPISEQ CS

Keep track of resistance and virulence genes profiles within hospital acquired infections
CDSS-AMS

Optimize antimicrobial prescription with decision-support
CDSS-HAI

Decision support to help prevent nosocomial infections

VIDAS BRAHMS PCT

Support discontinuation decisions

 

How can we help the AMS Committee?

bioMérieux can support you all along your AMS journey with a dedicated offer for AMS Committee members to start an AMS Program or help you to go to the next level and encourage prescription guideline compliance. Here’s what you can do:

MYLA

Aggregate data for resistance patterns within organism occurrence and cumulative antibiogram
MEDICAL EDUCATION MODULES

Showcase the medical and economic value of in vitro diagnostics to support AMS to clinicians and healthcare professionals in collaboration with the microbiology laboratory

MYLA

Aggregate data efficiently to capitalize on hospital resistance within microbiology data and antibiotic consumption data
MEDICAL EDUCATION MODULES

Provide Medical Education Modules on AMS actions/interventions to support AMS to clinicians and healthcare professionals in collaboration with the microbiology laboratory

CDSS-AMS

Decision support to optimize antimicrobial prescription
VITEK 2

Selective susceptibility reporting based on rules engine taking into consideration site specificities
MYLA

Complement VITEK 2 rules engine with patient demographic and complementary testing activities information

 

Additional Resources on Antimicrobial Stewardship

Check out our:

 

References

 

➤ Contact us for more information on AMS

Click to see products of this solution
The solution contains the products below. Click on the products to see the details
Pioneering diagnostics